Glycoproteins Market Size, Share, Growth, and Industry Analysis, By Type (N-linkage, O-linkage and Others), By Application (Hospital, Research Institutes and Others), Regional Insights, and Forecast To 2032

• 

  Request a Free sample to learn more about this report

GLYCOPROTEINS MARKET OVERVIEW

The global glycoproteins market size was USD 0.47 billion in 2023 and is projected to grow from USD 0.49 billion in 2024 to USD 0.64 billion by 2032, exhibiting a CAGR of 3.3% during the forecast period. Asia-Pacific holds leading position in glycoproteins market share in 2023.

A protein molecule that has a carbohydrate linked to it is known as a glycoprotein. Both the posttranslational modification known as glycosylation and the process can happen during protein translation. The protein's polypeptide side chains are covalently joined to the carbohydrate, which is an oligosaccharide chain (glycan). Glycoproteins are more hydrophilic than ordinary proteins because of the -OH groups of the sugars. This implies that compared to other proteins, glycoproteins are more drawn to water. The molecule's hydrophilic properties also contribute to the distinctive folding of the protein's tertiary structure. Simple sugars (such as glucose, galactose, mannose, and xylose), amino sugars (sugars with an amino group, such N-acetylglucosamine or N-acetylgalactosamine), and acidic sugars can all be found in the short, frequently branched molecule known as a carbohydrate (sugars that have a carboxyl group, such as sialic acid or N-acetylneuraminic acid).

The structure, reproduction, immune system, hormones, and defence of cells and organisms are all impacted by glycoprotein. On the outside of the lipid bilayer that makes up cell membranes, glycoprotein can be seen. They can operate in the aqueous environment thanks to their hydrophilic character, where they play a role in chemical binding and cell-cell recognition. In order to strengthen and stabilise a tissue, cells and proteins (such as collagen) must be cross-linked. Cell surface glycoproteins play a key role in this process. Plants can defy gravity because of the glycoprotein that exist in their cells.

Not only are glycosylated proteins essential for intercellular communication. Additionally, they facilitate intra-organ system communication. The grey matter of the brain is home to glycoprotein, which collaborate with axons and synaptosomes there. Glycoprotein can be hormones. Examples include erythropoietin and human chorionic gonadotropin (HCG) (EPO). The glycoprotein prothrombin, thrombin, and fibrinogen are necessary for blood coagulation. Glycoprotein may act as cell markers. Two polymorphic variants of the glycoprotein glycophorin A are responsible for the MN blood types. Only two amino acid residues separate the two kinds, yet it is enough to cause issues for someone receiving an organ donation from someone with a different blood group. Glycosylated proteins help to differentiate the Major Histocompatibility Complex (MHC) and H antigen of the ABO blood group.

COVID-19 Impact:

Increase in Employment Opportunities to Stir Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with glycoproteins experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The spike in CAGR is attributed to the glycoproteins market growth and demand returning to pre-pandemic levels once the pandemic is over.

The Covid-19 pandemic has caused both long-term and short-term changes in the pharmaceutical industry, expanding career prospects. The pharmaceutical industry is one of the biggest and most lucrative industries worldwide, and it need highly qualified workers. Businesses must keep up with both local and international technical advancements as well as national health norms. Finding workers who will fulfil industry requirements now mostly involves working with a reputed recruitment agency with experience in the pharmaceutical field.

During the Covid-19 pandemic, Glycoproteins market have taken center stage, outperforming other industries in terms of stock market performance and employment possibilities. It is crucial to match the correct candidate to a job post given the unexpected increase in employment opportunities. By collaborating with an industry expert, you may gain access to the specialized recruitment resources required to satisfy the rising need for workers while simultaneously attracting the most qualified applicants.

LATEST TRENDS

Rising Demand for Biopharmaceutical to Expand the Market

The market for glycoproteins is expanding as a result of rising biopharmaceutical demand. The most noticeable post-translational alteration that occurs on these protein medicines is glycoprotein. It is one of the essential qualities that needs careful examination for the best efficacy and security. In order to monitor the quality target product profiles of recombinant glycoprotein medicines, solutions for qualitative and quantitative measures of glycosylation are evaluated.

Request a Free sample to learn more about this report

GLYCOPROTEINS MARKET SEGMENTATION

• By Type

Based on type; the market is divided into N-linkage, O-linkage and others.

In terms of product, N-linkage is the largest segment.

• By Application

Based on application; the market is divided into hospital, research institutes and others.

In terms of application, hospital is the largest segment.

DRIVING FACTORS

Increased Prevalence of Chronic Diseases to Augment Market Growth

Increasing prevalence of chronic diseases such as diabetes and cancer are driving the Glycoproteins market growth. Glycoproteins are sugar and protein-containing molecules that allow for wholesome cell-to-cell communication in the human body. They function as barriers that stop carcinogens from harming cells and from causing alterations in cells that have previously been exposed to them. Many people make it a point to consume glycoproteins as part of a healthy diet in order to strengthen their immune systems and stop or slow the progression of cancer.

Numerous Clinical Trials to Boost Market Growth

The increasing number of clinical trials in various therapeutic areas is also driving the growth of the Glycoproteins market. Globally, clinical trials are required to help find innovative, safe, and effective treatments and vaccines that will help lessen the burden of disease. These treatments may be for infectious diseases, which are especially important in the world's poorest areas, or non-communicable diseases like cancer and diabetes. Clinical trials are expected to grow the market because glycoprotein aids in the treatment of such illnesses.

RESTRAINING FACTORS

Congenital Disorders to Restrain Market Growth

A group of diseases known as congenital disorders of glycosylation (CDG) are brought on by flaws in the N-linked glycosylation pathway. Glycoprotein aids in the treatment of diseases, but it also has the potential to spread some owing to defects in N-linked glycosylation, which is a serious issue. This element is predicted to limit market expansion.

• Request a Free sample to learn more about this report

•  

GLYCOPROTEINS MARKET REGIONAL INSIGHTS

North America to Dominate the Market Due to Growing Awareness About Glycoscience

North America dominates the glycoproteins market share and researchers and scientists in the region are becoming more aware of glycoscience. Excellent infrastructure for research and experiments has also helped the industry expand. Therefore, it is anticipated to see increased demand and, as a result, attract significant investments in the near future.

KEY INDUSTRY PLAYERS

Market Players to Boost Market Growth

The research provides an in-depth overview of the analysis of major aspects of the glycoprotein industry, including as sales value, sales volume, market revenue, and demand size, as well as sales growth, price analysis, and shifting regional market growth factors. The market participants and their relative positions within the industry are discussed in the report. Data is being collected and made available through proper research, mergers, technical advancement, growing production facilities, and cooperation. The study on materials contains information on producers, locations, types, applications, sales channels, and distributors.

List Of Top Glycoproteins Companies

• Sigma (U.S.)
• Creative Diagnostics (U.S.)
• R&D Systems (China)
• Enzo Life Sciences (U.S.)
• Thermo Fisher Scientific (U.S.)
• Epitope Diagnostics (U.S.)
• BD Biosciences (U.S.)

REPORT COVERAGE

The report examines market channels of glycoproteins market and provides information on the elements affecting probable future global development. Additionally, the report looks at market size and share, regional trends, end-use categories, and market segments. It emphasizes the importance of outlining an exhaustive regional analysis. The Global glycoprotein industry study also carried out a sector analysis to comprehend the key driving factors and entry barriers of the market. The paper also offers suggestions on how businesses might strengthen their market positions in light of significant alterations in the market dynamics.